Emerging disease information at your fingertips.
Provider
Resources
Providers &
Long Term Care
The resources you need, from treatment guidelines to the newest information on emerging conditions.
Recent Articles
→-
Health Advisory: Updated bivalent COVID-19 boosters authorized for children 6 months to 5 years old
Earlier this month, U.S. Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) expanded emergency use authorization (EUA) of Moderna and Pfizer-BioNTech bivalent vaccines for children 6 months and older. Updated (bivalent) COVID-19 booster vaccines are formulated to boost immunity against the original coronavirus strain and protect against the newer omicron … Health Advisory: Updated bivalent COVID-19 boosters authorized for children 6 months to 5 years old
-
12/19/22 Health Advisory: Antiviral Flu Treatment Interim Guidance
Be advised: Background Seasonal flu activity is high across the United States. Vaccination and antiviral treatment help prevent and control flu. U.S. Food and Drug Administration (FDA) approved 4 antivirals for early treatment of outpatients with flu: oseltamivir, baloxavir, zanamivir and peramivir. While FDA does not report shortages of oseltamivir in any of its forms, providers … 12/19/22 Health Advisory: Antiviral Flu Treatment Interim Guidance
-
12/19/22 Health Advisory: Newly Arrived Ukrainian Citizens’ Medical and Mental Health Needs
On April 21, 2022, President Biden announced a new Uniting for Ukraine (U4U) process to help Ukrainian citizens fleeing war come to the United States temporarily. As of Nov. 18, 2022: Newly arrived Ukrainian citizens have various medical and mental health needs. Resources